学术探索
学术期刊
新闻热点
数据分析
智能评审

Drug therapy - Hepatitis B virus infection

被引：724
作者：
Dienstag, Jules L. [1 ,2 ,3 ]
机构：
[1] Massachusetts Gen Hosp, Gastrointestinal Unit, Med Serv, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[3] Harvard Univ, Sch Med, Off Dean Med Educ, Boston, MA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 359卷 / 14期
关键词：
D O I：
10.1056/NEJMra0801644
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1486 / 1500
页数：15
相关论文
共 122 条
  • [1] BEASLEY RP, 1981, LANCET, V2, P1129
  • [2] Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy
    Bourne, E. J.
    Dienstag, J. L.
    Lopez, V. A.
    Sander, T. J.
    Longlet, J. M.
    Hall, J. G.
    Kwiatkowski, R. W.
    Wright, T.
    Lai, C. L.
    Condreay, L. D.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2007, 14 (01) : 55 - 63
  • [3] A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
    Chang, TT
    Gish, RG
    de Man, R
    Gadano, A
    Sollano, J
    Chao, YC
    Lok, AS
    Han, KH
    Goodman, Z
    Zhu, J
    Cross, A
    DeHertogh, D
    Wilber, R
    Colonno, R
    Apelian, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) : 1001 - 1010
  • [4] Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
    Chen, CJ
    Yang, HI
    Su, J
    Jen, CL
    You, SL
    Lu, SN
    Huang, GT
    Iloeje, UH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01): : 65 - 73
  • [5] Clinical significance of hepatitis B virus genotypes
    Chu, CJ
    Lok, ASF
    [J]. HEPATOLOGY, 2002, 35 (05) : 1274 - 1276
  • [6] Hepatitis B virus genotypes in the United States: Results of a nationwide study
    Chu, CJ
    Keeffe, EB
    Han, SH
    Perrillo, RP
    Min, AD
    Soldevila-Pico, C
    Carey, W
    Brown, RS
    Luketic, VA
    Terrault, N
    Lok, ASF
    [J]. GASTROENTEROLOGY, 2003, 125 (02) : 444 - 451
  • [7] One-year treatment with clevudine demonstrated significant viral suppression and biochemical improvement
    Chung, Y. H.
    Lee, K. S.
    Kim, J. H.
    Ryu, S. H.
    Paik, S. W.
    Um, S. H.
    Han, B. H.
    Cho, M.
    Byun, K. S.
    Kim, B. I.
    Park, J. W.
    Lee, H. J.
    Han, J. Y.
    Kim, H. C.
    Hwang, S. G.
    Yoo, K.
    Lee, Y. S.
    Lee, Y. J.
    Kim, Y. S.
    Yang, J. M.
    Chon, C. Y.
    Cho, S. H.
    Kim, Y. S.
    Choi, S. K.
    Kweon, Y. O.
    Han, C. J.
    Hwang, J. S.
    Lee, M. S.
    Kim, D. G.
    Lee, H. Y.
    Choi, J. Y.
    Yoo, H. W.
    Otto, M. J.
    Furman, P. A.
    Lee, H. S.
    Yoo, B. C.
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S25 - S25
  • [8] Four year assessment of ETV resistance in nucleoside-naive and lamivudine refractory patients
    Colonno, R. J.
    Rose, R. E.
    Pokornowski, K.
    Baldick, C. J.
    Eggers, B.
    Yu, D.
    Cross, A.
    Tenney, D. J.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 : S294 - S294
  • [9] EASL International Concensus Conference on Hepatitis B -: 13-14 September, 2002 Geneva, Switzerland Consensus Statement (Long version)
    de Franchis, R
    Hadengue, A
    Lau, G
    Lavanchy, D
    Lok, A
    McIntyre, N
    Mele, A
    Paumgartner, G
    Pietrangelo, A
    Rodés, J
    Rosenberg, W
    Valla, D
    [J]. JOURNAL OF HEPATOLOGY, 2003, 39 : S3 - S25
  • [10] When to start and stop hepatitis B treatment: Can one set of criteria apply to all patients regardless of age at infection?
    Degertekin, Bulent
    Lok, Anna S. F.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 147 (01) : 62 - 64
12345678910